Nearly 200 scientists, investors and industry representatives attended Weill Cornell Medicine’s 2025 Biomedical Innovation Conference (“BioInnovate”) April 1, sharing their startup journeys and experiences nurturing biomedical advances into health care products and companies.
The conference, hosted in the institution’s Uris Auditorium, featured a fireside chat with venture capitalist Alex Gorsky, general partner at investment firm ICONIQ Growth and the former chairman and CEO of Johnson & Johnson, as well as panels comprised of innovators, industry leaders and investors.
Speaking with Dr. John P. Leonard, senior associate dean for innovation and initiatives at Weill Cornell Medicine, Gorsky recounted the trail great science takes as it travels from the world of research to patient care.
“I think part of the secret sauce of America is that we have collaboration between all those institutions (government, academia, private sector) that make great innovations and breakthroughs possible,” Gorsky said.